Saturna Capital’s Biogen BIIB Stock Holding History

Saturna Capital’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-941	Closed	-$295K	–	159
2016 Q3	$295K	Buy	941 +13	+1%	+$3.85K	0.01%	142
2016 Q2	$224K	Buy	928 +127	+16%	+$33.5K	0.01%	153
2016 Q1	$217K	Hold	801	–	–	0.01%	159
2015 Q4	$245K	Sell	801 -4,085	-84%	-$1.17M	0.01%	167
2015 Q3	$1.43M	Buy	4,886 +1,874	+62%	+$619K	0.04%	114
2015 Q2	$985K	Buy	3,012 +2,942	+4,203%	+$1.18M	0.03%	136
2015 Q1	$30K	Buy	+70	New	+$27.6K	﹤0.01%	302

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Saturna Capital's BIIB Position: Q4 2016 in Review

Saturna Capital sold out of Biogen (BIIB) in Q4 2016, closing a stake of 941 shares — an estimated $295K sold.

Saturna Capital first reported a position in BIIB in Q1 2015 and held it in 7 quarters. The position peaked at $1.43M in Q3 2015. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

Saturna Capital reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
Saturna Capital sold 941 Biogen shares in Q4 2016, an estimated $295K.
Saturna Capital first reported a position in Biogen in Q1 2015 and held it in 7 quarters.
Saturna Capital's Biogen position peaked at $1.43M in Q3 2015.
1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on Saturna Capital's 13F filing for Q4 2016, filed 14 Feb 2017.